This inventor holds 1 USPTO granted patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Shareef Khalid: Innovator in Cerebrovascular Disease Treatment
Introduction
Shareef Khalid is a notable inventor based in White Plains, NY (US). He has made significant contributions to the field of medicine, particularly in the treatment of cerebrovascular diseases. His innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Shareef Khalid holds a patent for the "Treatment Of Cerebrovascular Disease With Neurogenic Locus Notch Homolog Protein 3 (NOTCH3) Agents." This patent represents a significant advancement in therapeutic options for patients suffering from cerebrovascular conditions. His work in this area is crucial for improving patient outcomes and enhancing treatment efficacy.
Career Highlights
Khalid is currently employed at Regeneron Pharmaceuticals, Inc., a leading biotechnology company known for its focus on developing innovative medicines. His role at Regeneron allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
Throughout his career, Shareef has worked alongside talented colleagues, including Juan Rodriguez-Flores and Alan Shuldiner. These collaborations have fostered an environment of innovation and have been instrumental in advancing their shared goals in medical research.
Conclusion
In summary, Shareef Khalid is a dedicated inventor whose work in cerebrovascular disease treatment is paving the way for new therapeutic approaches. His contributions to the field are invaluable, and his ongoing efforts at Regeneron Pharmaceuticals, Inc. continue to make a significant impact on healthcare.